Connection

ZHI TAN to Protein Kinase Inhibitors

This is a "connection" page, showing publications ZHI TAN has written about Protein Kinase Inhibitors.
Connection Strength

0.952
  1. Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor. Sci Rep. 2016 09 21; 6:33534.
    View in: PubMed
    Score: 0.371
  2. Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 Nov 19; 121(47):e2413108121.
    View in: PubMed
    Score: 0.163
  3. Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 05 24; 384(6698):885-890.
    View in: PubMed
    Score: 0.158
  4. Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 May 07; 121(19):e2322934121.
    View in: PubMed
    Score: 0.157
  5. Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer. Nat Med. 2018 05; 24(5):638-646.
    View in: PubMed
    Score: 0.103
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.